Setting the record straight

The NYT reports today that the FDA approved a new “three-in-one” pill for those with HIV/AIDS. With such good news and the large amount of funding this country has given to the cause, the U.S. public will have a difficult time understanding why organizations fighting HIV/AIDS may still have an ax to grind. That is when messaging becomes critical.